Okyo Pharma Limited ADR (OKYO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.3500 +0.0900 (+7.14%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.3900 +0.0400 (+2.96%) 19:54 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2024 | 03-2023 | 03-2022 | 03-2021 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,803 | -13,284 | -6,218 | -3,379 | N/A |
| Depreciation Amortization | 4 | 4 | 2 | 2 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | -298 | 886 | N/A |
| Other Working Capital | 2,670 | 3,946 | -1,024 | 1,045 | N/A |
| Other Operating Activity | 4,639 | 1,639 | 2,069 | -154 | 0 |
| Operating Cash Flow | $-9,491 | $-7,695 | $-5,468 | $-1,600 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -6 | -2 | -7 | N/A |
| Net Acquisitions | N/A | N/A | N/A | -11 | N/A |
| Investing Cash Flow | $N/A | $-6 | $-2 | $-18 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 2,000 | N/A | 7,593 | N/A |
| Common Stock Issued | 6,209 | 7,323 | 2,153 | 246 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -12 | 0 |
| Financing Cash Flow | $6,209 | $9,323 | $2,153 | $7,827 | $N/A |
| Exchange Rate Effect | 64 | -278 | -872 | 445 | N/A |
| Beginning Cash Position | 4,045 | 2,701 | 6,889 | 236 | N/A |
| End Cash Position | 827 | 4,045 | 2,701 | 6,889 | N/A |
| Net Cash Flow | $-3,219 | $1,345 | $-4,189 | $6,654 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,491 | -7,695 | -5,468 | -1,600 | N/A |
| Capital Expenditure | N/A | -6 | -2 | -7 | N/A |
| Free Cash Flow | -9,491 | -7,701 | -5,470 | -1,607 | 0 |